BELLUS Health(BLU)

14.74 0.00 0.0%

今开:0.0昨收:14.74
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:1.869211386E9

BELLUS Health的热门讨论

其他

BELLUS Health(BLU)2023-06-29 05:25

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075891  Act: 33  Size: 21 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-06-29 02:45

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-075744  Act: 34  Size: 28 KB 网页链接查看全文

其他

BELLUS Health(BLU)2023-06-29 04:15

$BELLUS Health(BLU)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000434  Act: 34  Size: 2 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-06-28 23:15

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-075656  Act: 34  Size: 34 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-06-17 04:25

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-072257  Act: 34  Size: 38 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-06-07 04:10

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-068517  Act: 34  Size: 457 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-06-03 04:30

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-067581  Act: 34  Size: 740 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-05-20 05:30

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-062771  Act: 34  Size: 5 MB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-05-13 04:06

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001157523-23-000831  Act: 34  Size: 58 KB 网页链接查看全文

财报披露

BELLUS Health(BLU)2023-05-13 04:36

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-059791  Act: 34  Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

BELLUS Health的最新讨论

祈福在春天2023-04-18 22:10

$BELLUS Health(BLU)$ 制药公司,股价涨一倍查看全文

张小丰2023-04-18 19:07

$BELLUS Health(BLU)$ 被GSK收购了。。。查看全文

产业链观察2023-04-18 16:04

#药闻简讯# 重磅!葛$葛兰素史克(GSK)$ 达成协议,收购$BELLUS Health(BLU)$ 每股 14.75美元或20亿美元,溢价约100%。
此次收购使葛兰素史克获得了camlipixant,这是一种潜在的同类最佳和高选择性的P2X3拮抗剂,目前正处于III期开发阶段,用于RCC成年患者的一线治疗。$美国生科ETF-SPDR(XBI)$查看全文

麦麸泡泡糖2022-06-30 03:18

$BELLUS Health(BLU)$ 之前10块买的,二期20年6月出的有点小崩2.5左右就剁了,没想到现在居然活了[吐血]查看全文

产业链观察2022-05-17 19:42

药闻▶$BELLUS Health(BLU)$ ATS2022上的海报
公布选择性P2x3拮抗剂治疗难治性慢性咳嗽的2b期试验--SOOTHE中24小时客观咳嗽频率的应答者分析。网页链接查看全文

牛唐2021-12-27 23:28

$BELLUS Health(BLU)$ 又一个近30%的收益。$蔚来(NIO)$ $特斯拉(TSLA)$查看全文

chuminhua2021-12-14 10:03

12月18日,Bellus Health 报告称,其实验性 P2X3 拮抗剂 BLU-5937 达到了 IIa 期研究的主要终点,与安慰剂相比,一个月后显着降低了 24 小时咳嗽频率。首席医疗官 Catherine Bonuccelli 建议 SOOTHE 试验的顶线结果表明“BLU-5937 的重要治疗益处及其潜在的同类最佳耐受性,观察到与味觉降低相关的...查看全文

产业链观察2021-12-14 03:03

药闻|2021年12月13日,开发用于治疗难治性慢性咳嗽("RCC")和其他超敏反应相关疾病的新型疗法的临床阶段生物制药公司$BELLUS Health(BLU)$ 今天宣布其用于治疗RCC的2b期SOOTHE试验中,50毫克和200毫克BID剂量的BLU-5937在主要终点上达到了统计学意义,24小时咳嗽频率在安慰剂调整后减少34%...查看全文

1 2 3 4 5

BELLUS Health的新闻

美股异动 | BELLUS Health(BLU.US)涨8.33% 2b期临床试验结果良好

格隆汇2月24日丨BELLUS Health(BLU.US)涨8.33%,报6.5美元。该公司昨日宣布2b期缓解顽固性慢性咳嗽(RCC)临床试验的结果良好,使BLU-5937成为潜在的同类最佳P2X3拮抗剂。该公司计划在第二季度请求食品和药物管理局(FDA)临床三期前会议,并在2022年下半年启动... 网页链接

BELLUS Health的公告

其他

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075891  Act: 33  Size: 21 KB 网页链接

其他

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075894  Act: 33  Size: 21 KB 网页链接

其他

$BELLUS Health(BLU)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-075865  Act: 33  Size: 21 KB 网页链接

其他

$BELLUS Health(BLU)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000434  Act: 34  Size: 2 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-075744  Act: 34  Size: 28 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-075656  Act: 34  Size: 34 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-072257  Act: 34  Size: 38 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-068517  Act: 34  Size: 457 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-067581  Act: 34  Size: 740 KB 网页链接

财报披露

$BELLUS Health(BLU)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-062771  Act: 34  Size: 5 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19